Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_assertion type Assertion NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_head.
- NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_assertion description "[In primary myxofibrosarcomas, MET overexpression, as a frequent event, is likely driven by 7q gains with mRNA upregulation, associated with important prognosticators, and independently predictive of worse outcomes, highlighting its possible causative function in tumor aggressiveness and potentiality as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_provenance.
- NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_assertion evidence source_evidence_literature NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_provenance.
- NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_assertion SIO_000772 20639860 NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_provenance.
- NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_assertion wasDerivedFrom befree-20140225 NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_provenance.
- NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_assertion wasGeneratedBy ECO_0000203 NP893111.RAJT5661ID2R0BpqXeBAa5BZLSY_V6x04k_OIsD0xcHLE130_provenance.